About
Drug Delivery Technology for Metabolic Indications
Areas of Focus
Categories
Drug Delivery & Formulation
Team (4)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
1,506
By Phase
PHASE2: 3NA: 2PHASE1: 5
By Status
COMPLETED: 7RECRUITING: 1ACTIVE_NOT_RECRUITING: 1NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07008456Lead Sponsor
A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
PHASE2Recruiting
102 participants
Started: Sep 12, 2025 · Completed: Jul 31, 2026
NCT05803772Lead Sponsor
A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test
PHASE2Completed
31 participants
Started: Mar 31, 2023 · Completed: Feb 12, 2024
NCT05385978Lead Sponsor
A Study of Distal Jejunal-release Dextrose in Obese Participants
PHASE2Active, not recruiting
150 participants
Started: Nov 1, 2022 · Completed: Nov 11, 2024
NCT05126914Collaborator
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
N/ANot yet recruiting
1,000 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2028
NCT05507502Lead Sponsor
Timing of Influenza Vaccination in Patients With Heart Failure
NAUnknown
40 participants
Started: Nov 23, 2021 · Completed: Jun 30, 2024
Locations (1)
Headquarters
Zug, Switzerland
Map
Loading map...